2011 Bipolar disorder Pharmaceuticals 
Mad in America
JANUARY 4, 2025
In 2011, Pigott published a paper titled STAR*D: A Tale and Trail of Bias, which laid out the protocol violations in detail, and Mad in America posted the documents that he had obtained through his FOI requests. As our society embraced the use of SSRI antidepressants, disability due to affective disorders dramatically increased.
Mad in America
OCTOBER 30, 2023
As of mid-2011, despite over 100 papers having been published, 11 prespecified outcomes had still not been reported. Nothing in Insel’s narrative would harm psychiatry’s guild interests or pharmaceutical interests. 147 One paper stated in the abstract that suicidal ideation was seen in only 0.7% This is mendacious.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mad in America
OCTOBER 10, 2023
With the explosion of more and more drugs in cabinets across the country, more and more children are dying—but still, pharmaceutical companies push their products, leading to yet more drugs and yet more deaths. Unlike the pharmaceutical industry, in our village community the pain of losing a single child was felt by all.
Mad in America
NOVEMBER 6, 2023
667 In an NIMH study of 547 patients that compared six-year outcomes for depressed people treated for the disorder and those who eschewed medical treatment, the treated patients were three times more likely than untreated ones to suffer a cessation of their principal social role and nearly seven times more likely to become incapacitated.
Mad in America
OCTOBER 21, 2023
Thomas Insel, director of the National Institute of Mental Health (NIMH) from 2002-2015, acknowledged in 2011, “Whatever we’ve been doing for five decades, it ain’t working. The psychiatric-pharmaceutical-industrial complex is fueled by the profits of Big Pharma, which have made a staggering amount of money from psychiatric drugs.
Expert insights. Personalized for you.
145 
Let's personalize your content